Federico Aletti obtained his Master degree in Biomedical Engineering and Ph.D. in Bioengineering from Politecnico di Milano in 2005 and 2009, respectively. He was the recipient of the “Enzo Belardinelli” doctoral prize of the Italian GNB (National Bioengineering Group) for outstanding Ph.D. thesis in the field of Biomedical Engineering. He was a Visiting Scholar at Michigan State University, U.S.A. for several months in the years 2007-2010, and a Visiting Professor at the Universidade Nove de Julho in Sao Paulo and Universidade Federal de Sao Carlos in Brazil in 2013. He has a been a Marie Curie Fellow of the European Union since 2014, first at the University of California San Diego (2014-2015) and then at Politecnico di Milano (2016). He has been teaching assistant of the course “Bioengineering of Autonomous Control Systems” at Politecnico di Milano since 2006. He is coordinator of one of the work packages of the European Union-funded project “ShockOmics” (2013-2017). He is coauthor of 17 peer-reviewed articles and one book chapter. He serves as a reviewer for several bioengineering and physiology journals, such as the IEEE Transactions on Biomedical Engineering; Physiological Measurement; Medical and Biological Engineering and Computing; Journal of Clinical Monitoring and Computing. He is a member of the IEEE Engineering in Medicine and Biology Society and of the American Physiological Society.
His research interest include cardiovascular physiology, disease and bioengineering; cardiovascular control; cardiovascular signal processing and modeling; hemodynamic monitoring and critical care; experimental models and multiscale modeling of circulatory shock. In particular, Dr. Aletti’s research goal is to achieve a multilevel description of the fundamental patho-physiology of shock by integration of data from transcriptomics, proteomics and metabolomics, in order to enhance the interpretative power of system level models, based mainly on the analysis of hemodynamic signals. As a Marie Curie fellow, he has also been working towards the design of new systems and strategies for the therapeutic treatment of trauma and hemorrhagic shock in the intensive care unit, by working on specific animal models as a preliminary step before a possible preclinical evaluation of such treatments.